Australia's most trusted
source of pharma news
Posted 20 December 2021 AM
PBAC has exercised its so-called 'use it or lose it' powers to rescind positive recommendations for nine drugs which have not been acted on by sponsors.
Outcomes from November's PBAC meeting revealed a further four medicines are off the hook - for now - after receiving a 12 month extension.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.